Pfizer

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Pfizer 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PFE

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. 

CEO
Albert Bourla
CEOAlbert Bourla
Employees
81,000
Employees81,000
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1849
Founded1849
Employees
81,000
Employees81,000

PFE Key Statistics

Market cap
135.76B
Market cap135.76B
Price-Earnings ratio
17.54
Price-Earnings ratio17.54
Dividend yield
6.98%
Dividend yield6.98%
Average volume
48.67M
Average volume48.67M
High today
$24.25
High today$24.25
Low today
$23.86
Low today$23.86
Open price
$24.20
Open price$24.20
Volume
28.05M
Volume28.05M
52 Week high
$31.54
52 Week high$31.54
52 Week low
$20.92
52 Week low$20.92

PFE News

TipRanks 4d
Oppenheimer surprised by ‘hasty’ decision to cull frontline Vepdeg development

Oppenheimer says the firm was surprised by the announcement that Arvinas (ARVN) and partner Pfizer (PFE) were culling development of Vepdegestrant in frontline...

Benzinga 5d
Pfizer CEO Albert Bourla Emphasizes National Security In US Drug Manufacturing

On Tuesday, Pfizer Inc. PFE reported first-quarter 2025 adjusted EPS of 92 cents, compared to 82 cents a year ago, beating the consensus of 67 cents. Sales fell...

Pfizer CEO Albert Bourla Emphasizes National Security In US Drug Manufacturing
Simply Wall St 5d
Pfizer Reports Q1 Earnings, Reaffirms 2025 Revenue Guidance at US$61-64 Billion

reported a decline in its Q1 2025 earnings, with revenue dropping from the previous year, alongside stagnant share buyback activities. Despite reaffirming reven...

Pfizer Reports Q1 Earnings, Reaffirms 2025 Revenue Guidance at US$61-64 Billion

Analyst ratings

63%

of 24 ratings
Buy
33.3%
Hold
62.5%
Sell
4.2%

More PFE News

Seeking Alpha 6d
Viking among notable gainers as Pfizer raises deal prospects

Viking Therapeutics (NASDAQ:VKTX) and other developers of oral weight loss drugs traded sharply higher on Tuesday after Pfizer (NYSE:PFE) CEO Albert Bourla indi...

Viking among notable gainers as Pfizer raises deal prospects
Benzinga 6d
Crude Oil Down Over 2%; Pfizer Shares Gain After Q1 Earnings

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining over 250 points on Tuesday. The Dow traded up 0.70% to 40,507.41 while the N...

Crude Oil Down Over 2%; Pfizer Shares Gain After Q1 Earnings
Benzinga 6d
Pfizer's Covid Windfall Shrinks, Expands Cost-Cutting Efforts

On Tuesday, Pfizer Inc. PFE reported first-quarter 2025 adjusted EPS of 92 cents, compared to 82 cents a year ago, beating the consensus of 67 cents. Pfizer’s...

Pfizer's Covid Windfall Shrinks, Expands Cost-Cutting Efforts
Sherwood News 6d
Pfizer beats earnings estimates thanks to cost cuts

Pfizer beats earnings estimates thanks to cost cuts Pfizer beat Wall Street earnings estimates for the first three months of this year, fueled largely by an ag...

Pfizer beats earnings estimates thanks to cost cuts
TipRanks 6d
Pfizer: Current guidance assumes no share repurchases in 2025

06:47 EDT Pfizer (PFE): Current guidance assumes no share repurchases in 2025 Published first on TheFly – the ultimate source for real-time, market-moving brea...

Benzinga 7d
Pfizer Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Pfizer Inc. PFE will release earnings results for the first quarter, before the opening bell on Tuesday, April 29. Analysts expect the New York-based company t...

Pfizer Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

People also own

Based on the portfolios of people who own PFE. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.